ALZN
ALZN
NASDAQ · Biotechnology

Alzamend Neuro Inc

$1.31
-0.04 (-2.96%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,871.0% upside
Low Target $24.59
Average Target $38.92
High Target $51.00
Current Price $1.31
Current
$1.31
Target
$38.92
$24.59 $38.92 avg $51.00
Scenario Analysis
Bear Case
$24.59
1,777.1%
Low target
Base Case
$38.92
+2,871.0%
Avg target
Bull Case
$51.00
+3,793.1%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.61
-49.8% from high
52-Week Low
$0.84
+56.0% from low
Target vs 52W High
$38.92
+1,391.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%